Guys , you're getting a little excited .
Remember , there were only 20 women on the trial in second remission and although results appear good for them they aren't statistically significant enough to impress the market and I' assuming the FDA too.
Can-004 results are the ones that have the potential to impress, with the much larger cohort .
Report attached, page-22
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
0.005(1.47%) |
Mkt cap ! $501.1M | |||
| Open | High | Low | Value | Volume |
| 33.5¢ | 34.8¢ | 33.5¢ | $932.8K | 2.725M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 29411 | 34.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 938315 | 11 |
View Market Depth
| Last trade - 16.10pm 26/09/2024 (20 minute delay) ? |
| IMM (ASX) Chart |